Key result
Low-dose prednisolone linked to ~26% lower serum creatinine in CCE-related acute renal failure.
Why the study?
The prognosis of renal cholesterol crystal embolism is poor and no optimal therapy has been established for CCE-related acute renal failure.
Does low-dose prednisolone improve acute renal failure in patients with cholesterol crystal embolism?
Observational (n=7)
Does low-dose prednisolone improve acute renal failure in patients with cholesterol crystal embolism?
Low-dose prednisolone may ameliorate acute renal failure caused by cholesterol crystal embolism, likely by reducing the inflammatory reaction surrounding affected renal vessels.
No takes yet. Share an insight, caveat, or question.
Low-dose prednisolone in CCE-related ARF remains hypothesis-generating; randomized trials needed before any practice change.
Nakayama et al. (2006) conducted an observational in Cholesterol crystal embolism (CCE)-related acute renal failure (n=7). Low-dose prednisolone was evaluated on Serum creatinine and eosinophil count. Low-dose prednisolone improved CCE-related acute renal failure, reducing mean serum creatinine from 4.2 mg/dl before treatment to 3.1 mg/dl at 4 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: